Financial Ratios Globe Life Inc.

Equities

GL

US37959E1029

Life & Health Insurance

Market Closed - Nyse Other stock markets 01:30:02 12/07/2025 am IST			5-day change	1st Jan Change
118.13 ^USD	-0.84%		-2.53%	+5.93%

10/07	Wells Fargo Raises Price Target on Globe Life to $144 From $139, Maintains Overweight Rating	MT
08/07	JPMorgan Adjusts Price Target on Globe Life to $160 From $145, Maintains Overweight Rating	MT

338cb6753eb597cf.r_mUJhpwkWF_f5d9yB1pgut_Kslk03OBRmliA1WbMSE.-JHBYSIJxzIlNO8zly0TypgySflTmwqsPDsBYXjNVmn6rKZndCHHLC8Q0g

Published financial data: GLOBE LIFE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Premiums and Annuity Revenues	381.39Cr	409.99Cr	430.27Cr	445.6Cr	466.63Cr
Total Interest And Dividend Income	93Cr	95Cr	99Cr	105.69Cr	113.56Cr
Gain (Loss) on Sale of Investments, Total (Rev)	-43.71L	5.93Cr	-7.65Cr	-6.57Cr	-2.42Cr
Other Revenues, Total	13.25L	12.16L	12.46L	3L	4L
Total Revenues	473.79Cr	511.29Cr	521.49Cr	544.75Cr	577.81Cr
Policy Benefits	257.29Cr	285.96Cr	286.55Cr	286.43Cr	289.44Cr
Policy Acquisition / Underwriting Costs, Total	88Cr	94Cr	100Cr	92Cr	100Cr
Selling General & Admin Expenses, Total	98L	1Cr	94L	1.92Cr	1.57Cr
Stock-Based Compensation (IS)	3.59Cr	3.03Cr	3.56Cr	3.07Cr	4.01Cr
Other Operating Expenses	25Cr	27Cr	31Cr	32Cr	36Cr
Total Operating Expenses	375.13Cr	410.89Cr	421.57Cr	415.01Cr	430.28Cr
Operating Income	99Cr	100.4Cr	100Cr	129.75Cr	147.53Cr
Interest Expense, Total	-8.67Cr	-8.35Cr	-9.04Cr	-10Cr	-13Cr
EBT, Excl. Unusual Items	90Cr	92Cr	91Cr	119.52Cr	134.82Cr
Legal Settlements	-32.75L	-81.39L	-24.96L	-9L	-2.16Cr
EBT, Incl. Unusual Items	90Cr	91Cr	91Cr	119.43Cr	132.66Cr
Income Tax Expense	16Cr	17Cr	17Cr	22Cr	26Cr
Earnings From Continuing Operations	73Cr	74Cr	74Cr	97Cr	107.08Cr
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	73Cr	74Cr	74Cr	97Cr	107.08Cr
Net Income - (IS)	73Cr	74Cr	74Cr	97Cr	107.08Cr
Net Income to Common Incl Extra Items	73Cr	74Cr	74Cr	97Cr	107.08Cr
Net Income to Common Excl. Extra Items	73Cr	74Cr	74Cr	97Cr	107.08Cr
Per Share Items
Net EPS - Basic	6.9	7.3	7.55	10.21	11.99
Basic EPS - Continuing Operations	6.9	7.3	7.55	10.21	11.99
Basic Weighted Average Shares Outstanding	11Cr	10Cr	9.79Cr	9.51Cr	8.93Cr
Net EPS - Diluted	6.82	7.22	7.47	10.07	11.94
Diluted EPS - Continuing Operations	6.82	7.22	7.47	10.07	11.94
Diluted Weighted Average Shares Outstanding	11Cr	10Cr	9.9Cr	9.64Cr	8.97Cr
Normalized Basic EPS	5.3	5.64	5.8	7.85	9.44
Normalized Diluted EPS	5.25	5.58	5.74	7.75	9.4
Dividend Per Share	0.75	0.79	0.83	0.9	0.96
Payout Ratio	10.69	10.74	10.89	8.66	7.98
American Depositary Receipts Ratio (ADR)	0.5	0.5	0.5	0.5	0.5
Supplemental Items
EBITDA	100.37Cr	102.4Cr	102.02Cr	131.85Cr	150.23Cr
EBITA	99Cr	100.4Cr	100Cr	129.75Cr	147.53Cr
EBIT	99Cr	100.4Cr	100Cr	129.75Cr	147.53Cr
EBITDAR	100.83Cr	102.87Cr	102.44Cr	132.2Cr	150.55Cr
Total Revenues (As Reported)	473.79Cr	511.29Cr	521.49Cr	544.75Cr	577.81Cr
Effective Tax Rate - (Ratio)	18.39	18.35	18.38	18.72	19.29
Current Domestic Taxes	-	-	-	-	-
Total Current Taxes	13Cr	14Cr	14Cr	15Cr	22Cr
Deferred Domestic Taxes	-	-	-	-	-
Total Deferred Taxes	3.53Cr	2.27Cr	2.84Cr	7.76Cr	3.77Cr
Normalized Net Income	56Cr	58Cr	57Cr	75Cr	84Cr
Interest on Long-Term Debt	7.74Cr	7.82Cr	8.05Cr	8.03Cr	9.11Cr
Non-Cash Pension Expense	93.65L	1.01Cr	24.16L	-63.43L	-84.4L
Supplemental Operating Expense Items
Advertising Expense	98L	1Cr	94L	1.92Cr	1.57Cr
Selling and Marketing Expenses	98L	1Cr	94L	1.92Cr	1.57Cr
Net Rental Expense, Total	46.74L	46.74L	42.39L	35.19L	32.08L
Imputed Operating Lease Interest Expense	18.05L	15.81L	14.94L	13.23L	12.16L
Imputed Operating Lease Depreciation	28.69L	30.93L	27.45L	21.96L	19.92L
Stock-Based Comp., Other (Total)	3.59Cr	3.03Cr	3.56Cr	3.07Cr	4.01Cr
Total Stock-Based Compensation	3.59Cr	3.03Cr	3.56Cr	3.07Cr	4.01Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Investment In Debt Securities	2.12TCr	2.13TCr	1.65TCr	1.79TCr	1.72TCr
Investment In Equity and Preferred Securities, Total	69Cr	54Cr	65Cr	65Cr	69Cr
Mortgage Loans	16Cr	57Cr	61Cr	69Cr	96Cr
Policy Loans	58Cr	59Cr	61Cr	66Cr	70Cr
Total Other Investments	11Cr	8.1Cr	14Cr	12Cr	13Cr
Total investments	2.28TCr	2.31TCr	1.85TCr	2TCr	1.96TCr
Cash And Equivalents	9.48Cr	9.22Cr	9.26Cr	10Cr	17Cr
Other Receivables - (Insurance Template)	72Cr	74Cr	74Cr	90Cr	96Cr
Deferred Policy Acquisition Costs - (BS)	459.54Cr	491.47Cr	524.99Cr	600.95Cr	649.56Cr
Gross Property Plant And Equipment	35Cr	38Cr	41Cr	46Cr	53Cr
Accumulated Depreciation	-16Cr	-17Cr	-19Cr	-22Cr	-24Cr
Net Property Plant And Equipment	19Cr	20Cr	21Cr	24Cr	28Cr
Goodwill	44Cr	48Cr	48Cr	48Cr	49Cr
Other Current Assets, Total	-	-	-	-	-
Other Long-Term Assets, Total	25Cr	25Cr	23Cr	33Cr	103.93Cr
Total Assets	2.9TCr	2.98TCr	2.55TCr	2.81TCr	2.91TCr
Liabilities
Insurance And Annuity Liabilities	1.53TCr	1.61TCr	1.68TCr	1.96TCr	1.86TCr
Unpaid Claims	40Cr	41Cr	43Cr	51Cr	53Cr
Unearned Premiums	6.17Cr	6.55Cr	6.07Cr	25Cr	26Cr
Current Portion of Long-Term Debt	-	15Cr	17Cr	17Cr	-
Current Portion of Leases	53.07L	-	-	-	-
Short-Term Borrowings	25Cr	33Cr	28Cr	32Cr	42Cr
Long-Term Debt	125.39Cr	110.59Cr	118.73Cr	132.68Cr	225.54Cr
Long-Term Leases	1.57Cr	-	-	-	-
Trust Preferred Securities (BS)	41Cr	44Cr	44Cr	44Cr	44Cr
Current Income Taxes Payable	183.37Cr	176.5Cr	69Cr	49Cr	73Cr
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	-	-	-	-	-
Deferred Tax Liability Non-Current	-	-	-	-	-
Other Non Current Liabilities	70Cr	72Cr	54Cr	49Cr	58Cr
Total Liabilities	2.03TCr	2.11TCr	2.06TCr	2.36TCr	2.38TCr
Common Stock, Total	11Cr	11Cr	11Cr	10Cr	9.72Cr
Additional Paid In Capital	53Cr	52Cr	53Cr	53Cr	53Cr
Retained Earnings	587.41Cr	618.21Cr	646.62Cr	747.88Cr	800.25Cr
Treasury Stock	-77Cr	-85Cr	-79Cr	-85Cr	-129.23Cr
Comprehensive Income and Other	302.92Cr	267.76Cr	-141.57Cr	-277.24Cr	-202.97Cr
Total Common Equity	877.11Cr	864.28Cr	489.59Cr	448.68Cr	530.55Cr
Total Equity	877.11Cr	864.28Cr	489.59Cr	448.68Cr	530.55Cr
Total Liabilities And Equity	2.9TCr	2.98TCr	2.55TCr	2.81TCr	2.91TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	10Cr	9.93Cr	9.65Cr	9.37Cr	8.38Cr
ECS Total Common Shares Outstanding	10Cr	9.96Cr	9.67Cr	9.38Cr	8.4Cr
Book Value / Share	84.5	86.8	50.61	47.84	63.18
Tangible Book Value	832.95Cr	816.1Cr	441.41Cr	400.5Cr	481.51Cr
Tangible Book Value Per Share	80.25	81.96	45.63	42.7	57.34
Total Debt	194.38Cr	202.61Cr	207.71Cr	225.37Cr	311.17Cr
Net Debt	184.9Cr	193.4Cr	198.45Cr	215.05Cr	294.63Cr
Debt Equivalent of Unfunded Proj. Benefit Obligation	23Cr	18Cr	6.28Cr	5.68Cr	2.02Cr
Debt Equivalent Oper. Leases	3.74Cr	3.74Cr	3.39Cr	2.82Cr	2.57Cr
Equity Method Investments, Total	31Cr	33Cr	32Cr	27Cr	27Cr
Account Code - Inventory Valuation	3	3	3	-	3
Full Time Employees	3.26T	3.22T	3.54T	3.64T	3.73T

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	73Cr	74Cr	74Cr	97Cr	107.08Cr
Depreciation, Depletion & Amortization	1.7Cr	2Cr	2.1Cr	2.1Cr	2.7Cr
Total Depreciation, Depletion & Amortization	1.7Cr	2Cr	2.1Cr	2.1Cr	2.7Cr
(Gain) Loss on Sale of Investments - (CF)	43.71L	-5.93Cr	7.65Cr	6.57Cr	2.42Cr
Amort. Of Deferred Policy Acq. Costs - (CF)	58Cr	60Cr	62Cr	38Cr	41Cr
Change In Income Taxes	8.82Cr	7.19Cr	5.07Cr	10Cr	7.79Cr
Change in insurance Reserves / Liabilities	83Cr	87Cr	86Cr	84Cr	75Cr
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities	-77Cr	-82Cr	-95Cr	-90Cr	-96Cr
Cash from Operations	147.64Cr	143.77Cr	142.22Cr	148.24Cr	140.24Cr
Capital Expenditure	-4.18Cr	-3.82Cr	-2.79Cr	-4.96Cr	-7.1Cr
Sale of Property, Plant, and Equipment	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	-112.4Cr	-81Cr	-89Cr	-72Cr	-41Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-88.87L	-52.55L	-2.52Cr	-16Cr	-16Cr
Other Investing Activities, Total	-70.51L	-5.67Cr	-	-	96T
Cash from Investing	-118.17Cr	-91Cr	-94Cr	-93Cr	-64Cr
Short Term Debt Issued, Total	-	7.5Cr	-	3.3Cr	48Cr
Long-Term Debt Issued, Total	70Cr	32Cr	25Cr	17Cr	53Cr
Total Debt Issued	70Cr	40Cr	25Cr	20Cr	101.47Cr
Short Term Debt Repaid, Total	-3.44Cr	-	-4.63Cr	-	-39Cr
Long-Term Debt Repaid, Total	-39Cr	-30Cr	-15Cr	-17Cr	-
Total Debt Repaid	-42Cr	-30Cr	-20Cr	-17Cr	-39Cr
Issuance of Common Stock	4.81Cr	6.98Cr	11Cr	11Cr	5.18Cr
Repurchase of Common Stock	-44Cr	-54Cr	-45Cr	-51Cr	-100.21Cr
Common Dividends Paid	-7.82Cr	-8Cr	-8.05Cr	-8.41Cr	-8.55Cr
Common & Preferred Stock Dividends Paid	-7.82Cr	-8Cr	-8.05Cr	-8.41Cr	-8.55Cr
Annuity Receipts	-	-	-	-	11Cr
Annuity Payments	-7.29Cr	-6.42Cr	-11Cr	-9.69Cr	-
Other Financing Activities, Total	-58.44L	-76.87L	-52.72L	-8L	-42Cr
Cash from Financing	-27Cr	-52Cr	-49Cr	-54Cr	-72Cr
Foreign Exchange Rate Adjustments	-17.33L	-33.91L	1.37Cr	-41.92L	1.71Cr
Net Change in Cash	1.89Cr	-26.84L	4L	1.06Cr	6.22Cr
Supplemental Items
Cash Interest Paid	8.35Cr	8.31Cr	8.88Cr	9.95Cr	12Cr
Cash Income Tax Paid (Refund)	7.67Cr	9.62Cr	11Cr	12Cr	18Cr
Net Debt Issued / Repaid	28Cr	10Cr	5.42Cr	3.73Cr	63Cr
Levered Free Cash Flow	143.25Cr	116.27Cr	10Cr	117.61Cr	144.2Cr
Unlevered Free Cash Flow	148.67Cr	121.49Cr	16Cr	124Cr	152.14Cr
Change In Net Working Capital	-28Cr	2.85Cr	111.72Cr	-4.72Cr	-19Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	2.24	2.13	2.26	3	3.23
Return on Total Capital	6.27	5.87	7.08	12.68	12.17
Return On Equity %	9.11	8.56	10.93	23.01	21.87
Return on Common Equity	9.11	8.56	10.93	23.01	21.87
Margin Analysis
Gross Profit Margin %	27.11	25.78	25.9	30.54	32.69
SG&A Margin	0.21	0.2	0.18	0.35	0.27
EBITDA Margin %	21.18	20.03	19.56	24.2	26
EBITA Margin %	20.82	19.64	19.16	23.82	25.53
EBIT Margin %	20.82	19.64	19.16	23.82	25.53
Income From Continuing Operations Margin %	15.44	14.57	14.18	17.82	18.53
Net Income Margin %	15.44	14.57	14.18	17.82	18.53
Net Avail. For Common Margin %	15.44	14.57	14.18	17.82	18.53
Normalized Net Income Margin	11.87	11.25	10.89	13.71	14.58
Levered Free Cash Flow Margin	30.24	22.74	1.99	21.59	24.96
Unlevered Free Cash Flow Margin	31.38	23.76	3.08	22.76	26.33
Asset Turnover
Asset Turnover	0.17	0.17	0.19	0.2	0.2
Fixed Assets Turnover	27.31	26.15	25.01	24.1	22.01
Short Term Liquidity
Current Ratio	0.36	0.33	0.58	0.62	0.63
Quick Ratio	0.26	0.24	0.43	0.47	0.49
Operating Cash Flow to Current Liabilities	0.58	0.53	0.87	0.85	0.72
Average Days Payable Outstanding	40.53	39.07	39.81	49.4	49.29
Long Term Solvency
Total Debt/Equity	22.16	23.44	42.42	50.23	58.65
Total Debt / Total Capital	18.14	18.99	29.79	33.43	36.97
LT Debt/Equity	19.19	17.89	33.25	39.39	50.82
Long-Term Debt / Total Capital	15.71	14.5	23.35	26.22	32.03
Total Liabilities / Total Assets	69.8	70.97	80.83	84.01	81.75
EBIT / Interest Expense	11.38	12.03	11.05	12.68	11.61
EBITDA / Interest Expense	11.63	12.27	11.29	12.89	11.82
(EBITDA - Capex) / Interest Expense	11.15	11.81	10.98	12.4	11.26
Total Debt / EBITDA	1.93	1.98	2.04	1.71	2.07
Net Debt / EBITDA	1.83	1.89	1.95	1.63	1.96
Total Debt / (EBITDA - Capex)	2.01	2.06	2.09	1.78	2.17
Net Debt / (EBITDA - Capex)	1.91	1.96	2	1.69	2.06
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	4.65	7.91	2	4.22	6.07
Gross Profit, 1 Yr. Growth %	-2.73	2.61	2.49	6.93	13.52
EBITDA, 1 Yr. Growth %	-3.49	2.03	-0.37	8.43	13.94
EBITA, 1 Yr. Growth %	-3.64	1.76	-0.48	8.58	13.71
EBIT, 1 Yr. Growth %	-3.64	1.76	-0.48	8.58	13.71
Earnings From Cont. Operations, 1 Yr. Growth %	-3.83	1.8	-0.71	8.54	10.3
Net Income, 1 Yr. Growth %	-3.81	1.8	-0.71	8.54	10.3
Normalized Net Income, 1 Yr. Growth %	-4.22	2.29	-1.27	8.2	12.81
Diluted EPS Before Extra, 1 Yr. Growth %	-0.15	5.87	3.46	11.39	18.57
Net Property, Plant and Equip., 1 Yr. Growth %	15.53	10.22	3.41	13.21	18.75
Total Assets, 1 Yr. Growth %	11.82	2.48	-14.21	7.95	3.65
Common Equity, 1 Yr. Growth %	20.25	-1.46	-43.35	13.6	18.25
Tangible Book Value, 1 Yr. Growth %	21.55	-2.02	-45.91	15.49	20.23
Cash From Operations, 1 Yr. Growth %	8.25	-2.62	-1.08	4.24	-5.4
Capital Expenditures, 1 Yr. Growth %	-1.06	-8.41	-26.97	77.42	43.37
Levered Free Cash Flow, 1 Yr. Growth %	-46.23	-18.83	-91.06	-983.47	22.61
Unlevered Free Cash Flow, 1 Yr. Growth %	-45.28	-18.28	-86.79	-1.72T	22.69
Dividend Per Share, 1 Yr. Growth %	8.7	5.33	5.06	8.43	6.67
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.92	6.27	4.91	3.23	5.14
Gross Profit, 2 Yr. CAGR %	2.05	-0.09	2.55	-0.79	10.17
EBITDA, 2 Yr. CAGR %	1.89	-0.77	0.82	-2.47	11.15
EBITA, 2 Yr. CAGR %	1.71	-0.98	0.63	-2.55	11.11
EBIT, 2 Yr. CAGR %	1.71	-0.98	0.63	-2.55	11.11
Earnings From Cont. Operations, 2 Yr. CAGR %	2.13	-1.05	0.54	-2.97	9.42
Net Income, 2 Yr. CAGR %	2.14	-1.05	0.54	-2.97	9.42
Normalized Net Income, 2 Yr. CAGR %	2.08	-1.02	0.49	-3.47	10.48
Diluted EPS Before Extra, 2 Yr. CAGR %	5.82	2.82	4.66	0.4	14.93
Net Property, Plant and Equip., 2 Yr. CAGR %	17.38	12.84	6.76	8.2	15.95
Total Assets, 2 Yr. CAGR %	12.15	7.05	-6.24	-2.93	5.78
Common Equity, 2 Yr. CAGR %	27.27	8.85	-25.29	-27.95	15.9
Tangible Book Value, 2 Yr. CAGR %	29.41	9.13	-27.2	-29.95	17.84
Cash From Operations, 2 Yr. CAGR %	7.5	2.67	-1.85	1.54	-0.7
Capital Expenditures, 2 Yr. CAGR %	-3.77	-4.81	-18.22	13.83	59.49
Levered Free Cash Flow, 2 Yr. CAGR %	13.39	-33.94	-73.06	3.26	229.12
Unlevered Free Cash Flow, 2 Yr. CAGR %	12.7	-33.13	-67.15	3.61	345.59
Dividend Per Share, 2 Yr. CAGR %	8.25	7	5.2	6.74	7.55
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.47	5.91	4.82	4.76	4.17
Gross Profit, 3 Yr. CAGR %	3.09	2.24	0.76	9.01	3.77
EBITDA, 3 Yr. CAGR %	2.71	1.94	-0.64	9.52	2.72
EBITA, 3 Yr. CAGR %	2.54	1.73	-0.81	9.56	2.59
EBIT, 3 Yr. CAGR %	2.54	1.73	-0.81	9.56	2.59
Earnings From Cont. Operations, 3 Yr. CAGR %	-20.53	2.02	-0.94	9.88	1.27
Net Income, 3 Yr. CAGR %	-20.47	2.03	-0.93	9.88	1.27
Normalized Net Income, 3 Yr. CAGR %	2.71	2.15	-1.11	9.92	1.67
Diluted EPS Before Extra, 3 Yr. CAGR %	-17.76	5.84	3.03	13.87	6.12
Net Property, Plant and Equip., 3 Yr. CAGR %	19.87	14.94	9.61	8.87	11.61
Total Assets, 3 Yr. CAGR %	7.36	8.83	-0.57	-1.16	-0.78
Common Equity, 3 Yr. CAGR %	12.07	16.86	-12.44	-20.02	-15.01
Tangible Book Value, 3 Yr. CAGR %	12.89	17.95	-13.64	-21.66	-16.13
Cash From Operations, 3 Yr. CAGR %	1.09	4.01	1.41	0.14	-0.82
Capital Expenditures, 3 Yr. CAGR %	27.21	-5.34	-12.86	5.87	22.93
Levered Free Cash Flow, 3 Yr. CAGR %	29.08	1.43	-66.08	-6.36	9.35
Unlevered Free Cash Flow, 3 Yr. CAGR %	34.34	1.25	-61.06	-5.87	9.62
Dividend Per Share, 3 Yr. CAGR %	7.72	7.27	6.35	6.27	6.71
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.7	5.38	4.65	4.83	5
Gross Profit, 5 Yr. CAGR %	3.78	3.92	2.87	6.17	7.42
EBITDA, 5 Yr. CAGR %	3.36	3.42	1.95	6.4	7.63
EBITA, 5 Yr. CAGR %	3.2	3.25	1.77	6.35	7.58
EBIT, 5 Yr. CAGR %	3.2	3.25	1.77	6.35	7.58
Earnings From Cont. Operations, 5 Yr. CAGR %	7.22	6.66	-12.69	6.71	7.07
Net Income, 5 Yr. CAGR %	6.78	6.26	-12.65	6.71	7.07
Normalized Net Income, 5 Yr. CAGR %	3.27	3.58	1.81	6.71	7.49
Diluted EPS Before Extra, 5 Yr. CAGR %	10.88	10.36	-9.43	10.58	11.82
Net Property, Plant and Equip., 5 Yr. CAGR %	17.51	16.14	14.44	12.2	12.1
Total Assets, 5 Yr. CAGR %	7.91	6.79	1.7	3.96	2.28
Common Equity, 5 Yr. CAGR %	16.68	13.61	-4.71	-3.69	-6.17
Tangible Book Value, 5 Yr. CAGR %	18.18	14.62	-5.28	-4.24	-6.81
Cash From Operations, 5 Yr. CAGR %	5.68	0.55	-0.1	3.02	0.56
Capital Expenditures, 5 Yr. CAGR %	2.47	8.73	6.6	1.9	10.98
Levered Free Cash Flow, 5 Yr. CAGR %	22.01	-3.24	-31.03	1.09	-11.55
Unlevered Free Cash Flow, 5 Yr. CAGR %	20.81	-3.11	-23.52	1.16	-10.95
Dividend Per Share, 5 Yr. CAGR %	6.79	7.12	6.71	7.06	6.83